Exagen Inc. (XGN)
Exagen Statistics
Share Statistics
Exagen has 17.9M shares outstanding. The number of shares has increased by 3.02% in one year.
| Shares Outstanding | 17.9M |
| Shares Change (YoY) | 3.02% |
| Shares Change (QoQ) | 1.48% |
| Owned by Institutions (%) | 33.1% |
| Shares Floating | 9.17M |
| Failed to Deliver (FTD) Shares | 50 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 60.84K, so 0.34% of the outstanding shares have been sold short.
| Short Interest | 60.84K |
| Short % of Shares Out | 0.34% |
| Short % of Float | 0.5% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -4.94 and the forward PE ratio is -19.53. Exagen's PEG ratio is 0.13.
| PE Ratio | -4.94 |
| Forward PE | -19.53 |
| PS Ratio | 1.34 |
| Forward PS | 1 |
| PB Ratio | 7.82 |
| P/FCF Ratio | -5.41 |
| PEG Ratio | 0.13 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Exagen.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.7, with a Debt / Equity ratio of 0.33.
| Current Ratio | 2.7 |
| Quick Ratio | 2.7 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | -0.29 |
| Debt / FCF | -0.23 |
| Interest Coverage | -6.1 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $266.22K |
| Profits Per Employee | $-72.32K |
| Employee Count | 209 |
| Asset Turnover | 1.25 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 12K |
| Effective Tax Rate | -0.08% |
Stock Price Statistics
The stock price has increased by 341.73% in the last 52 weeks. The beta is 1.46, so Exagen's price volatility has been higher than the market average.
| Beta | 1.46 |
| 52-Week Price Change | 341.73% |
| 50-Day Moving Average | 4.16 |
| 200-Day Moving Average | 3.56 |
| Relative Strength Index (RSI) | 66.15 |
| Average Volume (20 Days) | 131.37K |
Income Statement
In the last 12 months, Exagen had revenue of 55.64M and earned -15.12M in profits. Earnings per share was -0.83.
| Revenue | 55.64M |
| Gross Profit | 33.11M |
| Operating Income | -13.64M |
| Net Income | -15.12M |
| EBITDA | -11.14M |
| EBIT | -12.87M |
| Earnings Per Share (EPS) | -0.83 |
Balance Sheet
The company has 22.04M in cash and 3.18M in debt, giving a net cash position of 18.85M.
| Cash & Cash Equivalents | 22.04M |
| Total Debt | 3.18M |
| Net Cash | 18.85M |
| Retained Earnings | -294.33M |
| Total Assets | 44.69M |
| Working Capital | 22.95M |
Cash Flow
In the last 12 months, operating cash flow was -13.28M and capital expenditures -515K, giving a free cash flow of -13.79M.
| Operating Cash Flow | -13.28M |
| Capital Expenditures | -515K |
| Free Cash Flow | -13.79M |
| FCF Per Share | -0.76 |
Margins
Gross margin is 59.51%, with operating and profit margins of -24.51% and -27.17%.
| Gross Margin | 59.51% |
| Operating Margin | -24.51% |
| Pretax Margin | -27.14% |
| Profit Margin | -27.17% |
| EBITDA Margin | -20.03% |
| EBIT Margin | -24.51% |
| FCF Margin | -24.79% |
Dividends & Yields
XGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for XGN is $7.5, which is 22.1% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.5 |
| Price Target Difference | 22.1% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | -6.28 |
| Piotroski F-Score | 4 |